Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PSMA-PET”

391 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 391 results

Testing effectiveness (Phase 2)Looking for participantsNCT06904313
What this trial is testing

Ultralow Dose PET Imaging for PSMA Expression

Who this might be right for
Healthy VolunteerProstate CA
Akiva Mintz 200
Testing effectiveness (Phase 2)WithdrawnNCT04243941
What this trial is testing

PSMA-PET/MRI Low- and Intermediate-Risk Prostate Cancer

Who this might be right for
Prostate Cancer
UNC Lineberger Comprehensive Cancer Center
Not applicableLooking for participantsNCT05000827
What this trial is testing

Dutch National Randomized Study: PSMA-PET/CT As a Triage Tool for Pelvic Lymph Node Dissection in Prostatectomy Patients

Who this might be right for
Prostate Cancer MetastaticProstate CancerLymph Node Metastases
Canisius-Wilhelmina Hospital 706
Not applicableStudy completedNCT05522257
What this trial is testing

PSMA Expression and PSMA PET Imaging in Soft Tissue Sarcomas and Urothelial Cell Carcinomas

Who this might be right for
Sarcoma,Soft TissueUrothelial Carcinoma
Leiden University Medical Center 25
Not applicableStudy completedNCT05534594
What this trial is testing

Evaluation of the 18F-PSMA Positron Emission Tomography (PET)/CT in Patients With Medullary Thyroid Cancer

Who this might be right for
Medullary Thyroid CancerMedullary Thyroid CarcinomaThyroid Carcinoma, Medullary+1 more
University Medical Center Groningen 8
Very early researchStudy completedNCT05725070
What this trial is testing

Phase 0/1 Study of 212Pb-NG001 in mCRPC

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
ARTBIO Inc. 3
Not applicableStudy completedNCT07428642
What this trial is testing

PSMA PET/CT-Based Multimodal Model for Predicting Response to First-Line Therapy in mHSPC.

Who this might be right for
Metastatic Hormone-Sensitive Prostate CancerProstate Cancer
First Affiliated Hospital of Wenzhou Medical University 168
Not applicableStudy completedNCT02978586
What this trial is testing

A Pilot Study of [Ga-68]PSMA PET/MRI for the Assessment of PSMA-positive Tumors

Who this might be right for
Prostate-specific Membrane Antigen Positive TumorsProstate CancerBreast Cancer+1 more
Case Comprehensive Cancer Center 8
Testing effectiveness (Phase 2)Looking for participantsNCT07210086
What this trial is testing

Phase II Non-Randomized Study Evaluating POSLUMA-PSMA PET Response After Oligo- Metastatic/Progressive-directed Treatment With Radiotherapy (PROMPT-R)

Who this might be right for
Prostate Cancer
City of Hope Medical Center 50
Not applicableUnknownNCT03507595
What this trial is testing

Evaluation of the Metastasis and Recurrence of Prostate Cancer

Who this might be right for
Prostate Cancer (Diagnosis)Prostate Cancer MetastaticProstate Cancer Recurrent+1 more
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 400
Testing effectiveness (Phase 2)Study completedNCT04936334
What this trial is testing

The Role of 68Ga-PSMA-11 PET (Prostate Specific Membrane Antigen) in Surgery Guidance in Prostate Cancer

Who this might be right for
Prostate Cancer
Clinton Bahler 51
Early research (Phase 1)Active Not RecruitingNCT07236112
What this trial is testing

Study of TRDC002 in the Diagnosis of Patients With PSMA-positive Prostate Cancer

Who this might be right for
Prostate Cancer
C Ray Therapeutics 6
Very early researchStudy completedNCT03982407
What this trial is testing

68 Ga PSMA PET/MRI for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Ajit H. Goenka, MD 5
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07291557
What this trial is testing

PSMA-PET Directed Radiation Therapy for High-Risk Prostate Cancer

Who this might be right for
Prostate Cancer
AHS Cancer Control Alberta 250
Very early researchUnknownNCT05955677
What this trial is testing

Head-to-head Comparison of [68Ga]Ga-PSMA-D5 With [68Ga]Ga-PSMA-11 PET/CT in PCa Diagnosis, Recurrence, and Metastasis

Who this might be right for
Prostate CancerPET/CT
Anhui Provincial Hospital 100
Not applicableUnknownNCT04891536
What this trial is testing

Salvage Cryotherapy for Recurrent Prostate Cancer After Radiation Therapy

Who this might be right for
Prostate CancerCryotherapyRecurrent Prostate Cancer
Ignacio Puche Sanz 100
Not applicableUnknownNCT03903419
What this trial is testing

Feasibility Study of 68Ga-PSMA PET-CT and 18F-FDOPA PET-CT in Glioblastoma's Patients

Who this might be right for
Glioblastomas
Centre Leon Berard 16
Not applicableActive Not RecruitingNCT06359717
What this trial is testing

Prospective Validation of PSMA-RADS

Who this might be right for
Cancer Prostate
Zagazig University 477
Not applicableLooking for participantsNCT07511933
What this trial is testing

Novel Ga68-PSMA PET/CT-tracer to Differentiate Between Radiation Necrosis and Tumor Progression in Brain Metastases

Who this might be right for
Brain Metastases From Non-small Cell Lung Cancer (NSCLC)Brain Metastases From MelanomaBrain Metastases From Breast Cancer
The Netherlands Cancer Institute 100
Testing effectiveness (Phase 2)Study completedNCT03454750
What this trial is testing

Radiometabolic Therapy (RMT) With 177Lu PSMA 617 in Advanced Castration Resistant Prostate Cancer (CRPC)

Who this might be right for
Metastatic Castration Resistant Prostate Cancer68Ga-PSMA PET/CT Positive
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 143
Next Page